|
1
|
Sun B, Chen L, Tang E, Lin M. The immuno-therapeutic potential of miR-2392 in patients with hepatocellular carcinoma. Liver Int 2022; 42:2585-2586. [PMID: 35962762 DOI: 10.1111/liv.15395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Accepted: 08/11/2022] [Indexed: 02/13/2023]
Affiliation(s)
- Bin Sun
- Center for Clinical Research and Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai, P. R. China.,Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai, P. R. China
| | - Lei Chen
- Center for Clinical Research and Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai, P. R. China.,Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai, P. R. China
| | - Erjiang Tang
- Center for Clinical Research and Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai, P. R. China
| | - Moubin Lin
- Center for Clinical Research and Translational Medicine, Yangpu Hospital, Tongji University School of Medicine, Shanghai, P. R. China.,Department of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai, P. R. China
| |
Collapse
|